lysine has been researched along with baclofen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Brandt, NJ; Christensen, E; Gregersen, N; Grøn, IH; Rasmussen, K | 1 |
| Gähwiler, BH; Mouginot, D | 1 |
| Chen, CC; Cheng, SJ; Lin, CC; Lu, HC; Min, MY; Wang, HY; Wu, Y; Yang, HW | 1 |
| Hirsch, JC; Peusner, KD; Reddaway, R; Shao, M | 1 |
6 other study(ies) available for lysine and baclofen
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Treatment of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Experience with diet, riboflavin, and GABA analogue.
Topics: 2-Aminoadipic Acid; Amino Acid Metabolism, Inborn Errors; Aminobutyrates; Baclofen; Child; Diet Therapy; Dietary Proteins; Female; Glutarates; Humans; Lysine; Male; Oxidoreductases; Riboflavin; Tryptophan | 1979 |
Characterization of synaptic connections between cortex and deep nuclei of the rat cerebellum in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Baclofen; Bicuculline; Cerebellar Nuclei; Cerebral Cortex; Electrophysiology; GABA Agonists; gamma-Aminobutyric Acid; In Vitro Techniques; Lysine; Muscimol; Neural Pathways; Purkinje Cells; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Synaptic Transmission; Tetrodotoxin; Vestibular Nucleus, Lateral | 1995 |
GABAB receptor-mediated tonic inhibition of noradrenergic A7 neurons in the rat.
Topics: Analysis of Variance; Animals; Anisoles; Baclofen; Barium; Bee Venoms; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Gene Expression Regulation; In Vitro Techniques; Lysine; Male; Morpholines; Neural Inhibition; Neurons; Nipecotic Acids; Norepinephrine; Organophosphorus Compounds; Oximes; Patch-Clamp Techniques; Pons; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; RNA, Messenger | 2011 |
Presynaptic GABA(B) receptors decrease neurotransmitter release in vestibular nuclei neurons during vestibular compensation.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Baclofen; Chick Embryo; Excitatory Amino Acid Antagonists; GABA Agents; In Vitro Techniques; Lysine; Microscopy, Confocal; Microtubule-Associated Proteins; Neurons; Neurotransmitter Agents; Patch-Clamp Techniques; Presynaptic Terminals; Receptors, GABA-B; Sodium Channel Blockers; Statistics, Nonparametric; Synaptic Potentials; Synaptotagmin I; Synaptotagmin II; Tetrodotoxin; Time Factors; Valine; Vestibular Diseases; Vestibular Nuclei | 2012 |